Long‐term efficacy and predictive correlates of response to nivolumab in Japanese patients with esophageal cancer-Reference-Cited by-同舟云学术

Long‐term efficacy and predictive correlates of response to nivolumab in Japanese patients with esophageal cancer

Published:2020-04-29 Issue:5 Volume:111 Page:1676-1684
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Kato Ken¹^ORCID,Doki Yuichiro²,Ura Takashi³⁴,Hamamoto Yasuo⁵,Kojima Takashi⁶^ORCID,Tsushima Takahiro⁷,Hironaka Shuichi⁸⁹^ORCID,Hara Hiroki¹⁰,Kudo Toshihiro¹¹¹²,Iwasa Satoru¹,Muro Kei³,Yasui Hirofumi⁷,Minashi Keiko⁸,Yamaguchi Kensei¹⁰¹³,Ohtsu Atsushi¹⁴,Kitagawa Yuko¹⁵

Affiliation:

1. Department of Gastrointestinal Medical Oncology Division National Cancer Center Hospital Tokyo Japan

2. Department of Gastroenterological Surgery Osaka University Graduate School of Medicine Osaka Japan

3. Department of Clinical Oncology Aichi Cancer Center Hospital Nagoya Japan

4. Department of Clinical Oncology National Hospital Organization Kyoto Medical Center Kyoto Japan

5. Keio Cancer Center Keio University School of Medicine Tokyo Japan

6. Department of Gastroenterology and Gastrointestinal Oncology National Cancer Center Hospital East Kashiwa Japan

7. Division of Gastrointestinal Oncology Shizuoka Cancer Center Shizuoka Japan

8. Clinical Trial Promotion Department Chiba Cancer Center Chiba Japan

9. Department of Medical Oncology and Hematology Faculty of Medicine, Graduate School of Medicine Oita University Oita Japan

10. Department of Gastroenterology Saitama Cancer Center Saitama Japan

11. Department of Frontier Science for Cancer and Chemotherapy Osaka University Graduate School of Medicine Osaka Japan

12. Department of Medical Oncology Osaka International Cancer Institute Osaka Japan

13. Department of Gastroenterological Chemotherapy The Cancer Institute Hospital of Japanese Foundation for Cancer Research Tokyo Japan

14. National Cancer Center Hospital East Kashiwa Japan

15. Department of Surgery Keio University School of Medicine Tokyo Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cas.14380

Reference33 articles.

1. Cancer immunotherapy by targeting immune checkpoints: mechanism of T cell dysfunction in cancer immunity and new therapeutic targets

2. Toward integrative cancer immunotherapy: targeting the tumor microenvironment

3. Immunotherapy for advanced gastric and esophageal cancer: preclinical rationale and ongoing clinical investigations;Raufi AG;J Gastrointest Oncol,2015

4. The PD-1 pathway in tolerance and autoimmunity

5. PD-1 and PD-1 ligands: from discovery to clinical application

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Checkpoint Inhibitors in Esophageal Carcinoma;Surgical Oncology Clinics of North America;2024-01

2. Comparison of different predictive biomarker testing assays for PD-1/PD-L1 checkpoint inhibitors response: a systematic review and network meta-analysis;Frontiers in Immunology;2023-09-26

3. The impact of nutritional status in nivolumab-treated patients with advanced esophageal cancer;PLOS ONE;2023-05-05

4. Efficacy and safety of immune checkpoint inhibitors versus chemotherapy in the second-line treatment of advanced esophageal squamous cell carcinoma: a meta-analysis and systematic review;Journal of Thoracic Disease;2023-03

5. Tumour-infiltrating lymphocytes: from prognosis to treatment selection;British Journal of Cancer;2022-12-23